Regulatory Changes to Reshape Long-Term Care
Executive Insight
January 5, 2015
How will new regulatory changes impact the long-term care industry in 2015? In a recent article, Kendall Forbes, executive vice president of sales and operations at Guardian Pharmacy, writes about the Drug Enforcement Administration’s recent reclassification of hydrocodone combination products from Schedule III to Schedule II drugs as well as new standards for drug disposal.
